Alligator Bioscience appoints Søren Bregenholt as new CEO
Lund, Sweden, March 18, 2021 – Alligator Bioscience (Nasdaq Stockholm: ATORX) today announced that the Board of Directors has appointed Søre ...
Alligator Bioscience appoints Chief Scientific Officer
Lund, Sweden, January 15, 2021 – Alligator Bioscience (Nasdaq Stockholm: ATORX) today announced that the company has appointed Peter Ellmark ...
Alligator Bioscience recruits new Chief Medical Officer
Lund, Sweden, December 29, 2020 – Alligator Bioscience (Nasdaq Stockholm: ATORX) today announced that the company has appointed Dr Christina ...
Alligator Bioscience appoints Gayle Mills as Chief Business Officer
Lund, Sweden, September 28, 2020 – Alligator Bioscience (Nasdaq Stockholm: ATORX) announced today the appointment of Gayle Mills as Chief Bu ...
Alligator Bioscience appoints new CFO
Lund, Sweden, June 15, 2020 – Alligator Bioscience (Nasdaq Stockholm: ATORX) today announced the appointment of Marie Svensson as Chief Fina ...
Alligator Bioscience appoints Andreas Johannesson as interim Chief Financial Officer
Lund, Sweden, 5 March 2020 – Alligator Bioscience (Nasdaq Stockholm: ATORX) announced today that Andreas Johannesson has been appointed inte ...
CFO Per-Olof Schrewelius leaves Alligator Bioscience
Lund, Sweden, December 11, 2019 – Alligator Bioscience (Nasdaq Stockholm: ATORX), today announced that CFO (Chief Financial Officer) Per-Olo ...
Alligator Bioscience AB appoints Chief Operating Officer
Lund, November 29, 2019 – Alligator Bioscience (Nasdaq Stockholm: ATORX today announced that the company has appointed Dr Malin Carlsson as ...
Alligator Bioscience appoints new VP Business Development
Lund, Sweden, 18 January – Alligator Bioscience (Nasdaq Stockholm: ATORX), a biotechnology company developing antibody-based pharmaceuticals ...